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HRAbstract The purpose of the present study was to rate the level of spread of the morphological
changes on chest X-ray (CXR), using the modiﬁed Shwachman–Kulczycki (S–K) rating scale, in
relation to changes in routinely measurable parameters in outpatient clinic, such as frequency of
respiration (FR), heart rate (HR), wheeze (WHZ) and peak expiratory ﬂow (PEF). Asthma patients
were classiﬁed into 4 groups; Group-1 6 2 visits per week with reversible symptoms, Group-2 two
visits per week with irreversible symptoms, Group-3: 3–4 visits per week with irreversible symptoms;
Group-4: patients with severe shortness of breath in whom SaO2 was threatening, hence were
admitted as inpatients. CXR for group-2 showed bilateral increase in perihelia marking, broncho-
vascular markings but normal lungs ﬁelds and ruled out for costophrenic angles. Group-3 showed
hyperinﬂation, obvious perihelia marking associated with bronchial thickening and blocking as well
as unfolding aorta, with signiﬁcantly (p< 0.05) lower PEF, higher HR, FR and WHZ than group 1
and 2. There was also some evidence of bronchial edema with clearly observed ﬂeeting terminal
bronchial opacities. CXR for Group-4 showed, extensive atelectasis secondary to obstruction
and infection due to bronchiolitis and/or signs of right heart failure. Intra-classcorrelation coefﬁ-
cient showed a signiﬁcant (p< 0.05) reliability among evaluators of CXR, implying its consistent
applicability. Based on the results of the present study it can be concluded that monitoring PEF,
FR, WHZ and HR parameters in outpatient clinic can be an objective estimate of the S–K score
in order to classify the severity of asthma-induced-morphological changes in CXR.
ª 2014 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.Introduction
Asthma is a lung disease that is characterized by inﬂammation,
obstruction, and hyper responsiveness of the airways. Acute
inﬂammation is nonspeciﬁc response of tissue injury and may
lead to tissue repair. In contrast asthma represents a chronic
inﬂammatory process of the airways followed by healing whose
end results involve altered morphology of the airways referred
to as remodeling [35,23,25] which in turn leads to a widespread
790 A.-S.A. Haffor, M. Ismaeelnarrowing at different degrees of severity. Narrowing of the air-
ways causes recurrent episodes of wheezing, dyspnea, chest
tightness, cough, tachypnea and tachycardia particularly at
night and/or in the early morning. The inﬂammation also
causes an associated increase in airway responsiveness to stim-
uli speciﬁc to bronchospasm, edema andmucus hyper-secretion
[7,2,22,41]. The assessment of asthma progressions has been
made based on pulmonary function, physical examination
and chest X-ray (CXR) [1,31]. Although no single parameter
has been identiﬁed to assess the severity of asthma, CXR is a
useful method of assessment of asthma because it helps to
exclude other pathological conditions such as edema, broncho-
genic carcinoma, left ventricular failure, and bronchiectasis. A
chest X-ray (CXR) includes the chest, airways, lungs, heart,
large arteries, ribs, and diaphragm; hence it involves many use-
ful clinical information and organs that can be affected by the
morphological alterations of the airways that underlie the path-
ological consequences manifested by chronic inﬂammations in
the airways [11]; In addition CXR provides a rough estimate of
the degree of hyperinﬂation like diseases such as emphysema
and in revealing complications or alternative causes of wheez-
ing [10,40,42] as well as it provides more useful information
in the initial diagnosis of bronchial asthma in excluding compli-
cations such as pneumonia.
The quantitative rating scale of the radiological appear-
ances on CXR in asthma can be interpreted in terms of the
impact of underlying chronic inﬂammations of the bronchial
tree. Thus it provides useful diagnostic proﬁle as well as it
points out the status about patient responses to treatment
and healing [20,21,28,32]. Furthermore a numerical prediction
of CXR rating score based on regularly measured parameters
such as breathing rate (FR), heart rate (HR), peak expiratory
ﬂow (PEF) and wheezing; allows for its implementations in
primary care clinic and in general physician ofﬁce without
the need for X-ray equipments. Despite this applicable and
useful tool for the management of asthma, the literature lacks
a quantitative rating score regarding the severity of asthma as
it appears on CXR.
The Shwachmann–Kulczycki (S–K) score published seven
decades ago [39], was the ﬁrst rating scale to assess the severity
of cystic ﬁbrosis – CF on CXR. It was developed to provide
the perceived overall clinical status and radiological evaluation
and represented a corner stone in the history of CF. The pres-
ent study is the ﬁrst report to implement the S–K scoring sys-
tem in asthma. Our goal was to implement the S–K scoring
system to classify asthma severity in a single numerical score
from regularly measurable parameters in outpatient clinic such
as peak expiratory ﬂow (PEF), wheezing (WHZ), frequency of
respiration (FR) and heart rate (HR).
We have derived a simple regression equation from regu-
larly measurable parameters (in general physician ofﬁce and
in primary care outpatient clinics) to provide a single numeri-
cal score to classify the severity of asthma induced CXR mor-
phological changes.
Materials and methods
Sample selection
A sample of 40 adult asthmatic patients, ranging in age from
20 to 55 years old were classiﬁed into four groups of differentseverities of asthma; intermittent, mild persistent, moderate
persistent, and severe. Asthma patients with additional clinical
conditions related to cancer, eczema, and chronic illnesses (dia-
betes mellitus, chronic kidney disease, etc.), or chronic inﬂam-
mation (rheumatoid arthritis, cigarette smokers) were excluded
from the study.
Physical examination
A Chest disease physician conducted patients’ physical exam-
inations that included but not limited to frequency of respira-
tion (FR), auscultation of the chest wheezing (WHZ), heart
rate (HR) and reviewing chest X-ray (CXR).
Modiﬁed Schwachman-Kulczki (S–K) Rating Scale of the
Chest X-ray
The Schwachman–Kulczki (S–K) scale was originally con-
ducted on cystic ﬁbrosis patients with a numerical value of
25 for healthy and 5 for most severe [39,27]. We modiﬁed
the S–K scale by excluding the ﬁrst category for healthy and
the modiﬁed scale score used in the present study ranged from
5 to 20 with 5 being the most severe and 20 being the least
severe asthma. We also allowed a range of 3 in each category
to allow for more accuracy by the evaluators. For example a
range of 3 to 5 (rather than single point of 5) wherein 3 is
observed severe signs at best, 4 observed severe signs, and 5
observed severe signs at least. Similarly 8–10 range implied 3
observations of moderate signs, 13–15implied a range of mild
signs and 18–20 implied a range of intermittent signs of
asthma.
Statistical analysis
Statistical analysis was conducted using SPSS for Windows,
v.16 (SPSS Inc., Chicago, IL, USA). Data were tested for nor-
mality using normal probability subroutine. A One Way Anal-
ysis of variance was used to evaluate groups’ mean differences.
Tukey, post hoc multiple comparisons, was used to conduct
pair-wise mean comparisons. The effects of the independent
variables (PEF, WHZ, FR, HR) on the outcome variable (S–
K score) were evaluated using step-wise multiple regression
analysis. The linearity and correlation among variables studied
were generated using Pearson product moment correlation.
Intra-class multiple correlations were used to evaluate the reli-
ability of the S–K rating score of the chest X-ray (CXR) image
based on the evaluators’ pathological observations [44].
Results
Descriptive ﬁndings
Descriptive ﬁndings of the modiﬁed Shwachman–Kulczki rating
scale
The average S–K rating score of the assessment of patients’
chest X-ray (CXR) of asthma severity of the three evaluators
for all groups are presented in Table 1.
Table 2 presents information regarding patients’ classiﬁca-
tion, CXR pathological ﬁndings, frequency of symptoms and
related physiological measures. The criteria used to score the
Table 1 Descriptive Statistics of the Modiﬁed Shwachman-
Kulczki Rating Score.
Evaluator Group Membership Mean Std. deviation N
First evaluator Group1 18.8000 2.29976 10
Group2 14.4000 1.57762 10
Group3 9.2000 2.82056 10
Group4 5.0000 1.24722 10
Second Evaluator Group1 18.6000 1.77639 10
Group2 14.6000 .96609 10
Group3 9.3000 2.66875 10
Group4 4.9000 1.66333 10
Third Evaluator Group1 19.0000 1.69967 10
Group2 14.5000 1.26930 10
Group3 9.2000 3.04777 10
Group4 5.6000 1.50555 10
Grading chest X-ray in adult asthma 791pathological signs on the X-ray image for the ﬁrst group were:
(a) the presence of unilateral peri-bronchial thickening without
obvious mediastinum vascular abnormality. The criteria for
the second group were; bilateral peri-bronchial thickening with
tram-track pattern associated with branched bronchial thick-
ness as well as pulmonary nodules. For group three; obvious
bronchial thickness and air trapping associated with segmental
atelectasis [9,14]; due to mucus hypersecretion and blocking
associated with obvious vascular abnormalities as well as
abnormal heart size and shadow. For the fourth group; exten-
sive atelectasis secondary to obstruction and infection due to
bronchiolitis and/or signs of right heart failure [25].
Descriptive ﬁndings of physiological measures
The average (±SD/SE) values of selected physiological mea-
sures of each group, along with related physiological measures
are presented in Table 3. These physiological measures
included peak expiratory ﬂow (PEF), frequency of respiration
(FR), heart rate (HR), saturation of O2 in arterial blood
(SaO2) and wheeze (WHZ). Clearly those physiological mea-
sures were carefully chosen as they represent multiple unique
combinations of integrated sensor to differentiate between dif-
ferent levels of severities of asthma-induced-broncho-constric-
tion. The average values of the three evaluators regarding S–K
score of each group, along with related physiological measures,
are presented in Table 3.
Inferential ﬁndings
Relationship between S–K and the physiological measures
The Shwachman-Kulczycki(S–K) radiological score was found
to correlate positively with PEF (r= 0.0.98, p< 0.000) and
negatively related with FR (r= 0.98, p< 0.000), wheezing
(r= .971, p< 0.000) and heart rate (r= 0.94, p< 0.000).
Findings of the regression of S–K on physiological measures
Stepwise multiple regression analysis results showed that the
best subsets to predict S–K were model 4 that included peak
expiratory ﬂow (PEF), frequency of respiration (FR), wheez-
ing (WHZ) and heart rate (HR) (Table 4). As can be seen from
Table 4 the regression sum of squares of the model was signif-
icant (p< 0.05).As noted from Table 5 the model terminated after adding
all the 4 independent explanatory variables with signiﬁcant
(p< 0.05) impact on Shwachman–Kulczycki score rating
scored on the S–K scale of chest X-ray image. The ﬁrst vari-
able entered into the model was peak expiratory ﬂow (PEF)
with a p value of 0.000. The second variable entered into the
model was wheezing (WHZ) with a p value of 0.001. The third
variable entered into the model was heart rate (HR) with a p
value of 0.01. The fourth variable entered into the model
was frequency of respiration (FR) with a p value of 0.03.,
implying that all four predicted variables entered in the model
had signiﬁcantly (p< 0.05) improved the prediction of Shw-
achman–Kulczycki score rating appeared as
where bS–K ¼ b1PEF þ b2WHZ þ b3HR þ b4FR þ 
S–K ¼ 19:866þ b1ð0:103Þ þ b2ð:796Þ þ b3ð0:053Þ
þ b4ð0:155Þ þ Reliability of the results of modiﬁed Shwachman–Kulczki rating
scale (S–K)
The reliability of the modiﬁed S–K score was evaluated using
intra-class correlation. A repeated measures uni-variate analy-
sis, via SPSS-GLM procedure, for the 3 evaluators’ rating
score for all images of the four groups of asthma patients;
namely mild, moderate, heavy and severe asthma (Table 6)
was used. This analysis was conducted to calculate an estimate
of reliability and the concurrent validity among the three eval-
uators regarding their rating scores for the observed clinical
signs as they appeared on an X-ray image. Clearly shown from
Table 6, the overall model (corrected model) for building reli-
ability analysis was signiﬁcant (p< 0.05), that is the design
that was chosen for analysis can be trusted to establish within
evaluators among groups’ reliability. Furthermore the mean
square among the 3 evaluators for given image was not signif-
icant (p> 0.05), nor the interaction effects were signiﬁcant
(p> 0.05), implying consistent pattern of the evaluators
for judging the X-ray image among groups being studied
(mild, moderate, heavy and severe asthma images). As can
be seen from Table 4, the total observed mean square
between groups (r2BG) = 1068.164, subtracting the within
trial mean square (within evaluators) yields an estimate of
individual differences (r2trials). In this situation, r
2
trials =
1068.164  0.675 = 1067.489. The ratio of r2trials/r2BG (i.e.,
the ratio of the true variance to the total observed variance)
is an estimate for reliability, which is = 1067.489/
1068.164 = 0.9993[44]. It can be concluded that there were
consistent, linear, and equivalent tendencies between S–K
score over repeated trials by different evaluators.
In addition, the ﬁndings that differential S–K rating scores
were signiﬁcant (p< 0.05) for all groups (Table 7), as evident
by the multiple comparisons of rating scores, conﬁrmed that
the clinical signs on the X-ray images of mild, moderate, heavy
and severe asthma patients were signiﬁcantly different among
groups.
Contrarily the differential ratings among evaluators were
not signiﬁcantly (p> 0.05) different (Table 8) implying consis-
tency and objectivity among evaluators in differentiating and
identifying the clinical signs in the X-ray images for all patient
groups (Fig. 1).
Table 2 Summary of patients’ classiﬁcations based on CXR, S–K Score, and physiological measures that included; PEF, FR, HR and WHZ.
Group classiﬁcation Number of visitations CXR ﬁndings S–K score*!! PEF
(% of predicted)
FR* (BPM) HR* (BPM) WHZ*!
Group-1
Intermittent
<1 time a week
Asymptomatic and normal
breathing characteristics between
attacks
Normal lung size, normal costophrenic angle,
normal heart shadow with well deﬁned
border.
Minor appearance of unilateral peri-bronchial
thickness (shadow)-on one side
18.8 ± 0.02 78 + 1.29 17.8 ± 0.32 89.70 ± 1.49 1 ± 0.0
Occur at the end of
expiration
Group-2
Persistent (Mild)
>1 time a week
Attacks may aﬀect activity
Increased appearance of bilateral peri-
bronchial shadow
14.5 ± 0.10 61.5 ± 1. 82 23.1 ± 0.23 116.40 ± 1.44 2 ± 0.0
Occur throughout
expiration
Group-3
Persistent (Moderate)
Daily
>2–3 time a week but <1 time a
day
Attacks may aﬀect activity
More Intense appearance of bilateral peri-
bronchial shadow and nodules segmental
localized atelectasis, some (minor), pneumo-
mediastinum
9.2 ± 0.06 38.6 + 0.61 32.6 ± 0.54 127.30 ± 1.11 3 ± 0.0
Occur throughout
expiration and some
inspiration
Group-4
Persistent (Severe)
Daily
Attacks aﬀect activity
Extensive atelectasis secondary to obstruction
and infection due to Bronchiolitis and spread
of inﬂammations. Signs of right heart failure,
pulmonary (not viral) and broncho-
pulmonary (not viral) aspergillosis.
5.0 ± 0.37 23.8 + 0.32 41.40 ± 0.43 138.40 ± 0.27 4.53 ± 0.17
Occur throughout
expiration and
inspiration
* Values are average ± SE.
*! Smallest value represents the highest severity.
*!! Largest value represents least severity.
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Table 3 Descriptive statistics of the physiological measures.
Measure N Mean Std. deviation Std. error
PEF G1 10 78.0000 4.10961 1.29957
G2 10 61.5000 5.75905 1.82117
G3 10 38.6000 1.95505 .61824
G4 10 23.8000 1.03280 .32660
FR G1 10 17.8000 1.03280 .32660
G2 10 23.5000 1.77951 .56273
G3 10 32.3000 1.70294 .53852
G4 10 41.4000 1.34990 .42687
WHZ G1 10 1.0000 .00000 .00000
G2 10 2.0000 .00000 .00000
G3 10 3.0000 .00000 .00000
G4 10 4.5000 .52705 .16667
HR G1 10 89.70 4.71522 1.49108
G2 10 116.40 4.57530 1.44684
G3 10 127.30 3.52924 1.11604
G4 10 138.40 .84327 .26667
Table 4 Multiple regression models.
Model Sum of squares df Mean square F Sig.
1 Regression 1189.670 1 1189.670 1.471e3 .000a
Residual 30.730 38 .809
Total 1220.400 39
2 Regression 1201.359 2 600.680 1.167e3 .000b
Residual 19.041 37 .515
Total 1220.400 39
3 Regression 1205.488 3 401.829 970.102 .000c
Residual 14.912 36 .414
Total 1220.400 39
4 Regression 1207.383 4 301.846 811.576 .000d
Residual 13.017 35 .372
Total 1220.400 39
eDependent variable: score.
a Predictors: (constant), peak expiratory F.
b Predictors: (constant), peak expiratory F, WHZ.
c Predictors: (constant), peak expiratory F, WHZ, HR.
d Predictors: (constant), peak expiratory F, WHZ, HR, FR.
Table 5 Model 4 parameters.
Model Un-standardized coeﬃcients Standardized coeﬃcients t Sig.
B Std. Error Beta
4 (Constant) 19.866 3.771 5.268 .000
Peak expiratory F .103 .028 .394 3.729 .001
WHZ .796 .294 .190 2.710 .010
HR .053 .014 .176 3.653 .001
FR .155 .069 .254 2.257 .030
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In order to grade asthma severity and assess management
treatment response, we have derived a simple regression
equation from regularly measurable parameters (in generalphysician ofﬁce and in primary care outpatient clinics) to pro-
vide a single numerical score to classify the severity of asthma-
induced CXR morphological changes. The major ﬁndings of
the present study accomplished the current need for objective
standard scoring system for assessing chest X-ray (CXR) in
Table 6 GLM univariate analysis of variance: tests of between evaluator effects.
Source Type III Sum of Squares df Mean Square F Sig.
Corrected model 3208.425a 11 291.675 73.963 .000
Intercept 17064.675 1 17064.675 4.327e3 .000
Sum of squares among evaluators (SSA) 1.350 2 .675 .171 .843
Sum of squares among groups (SSB) 3204.492 3 1068.164 270.866 .000
Interaction Eﬀect (SSA* SSB) 2.583 6 .431 .109 .995
Error 425.900 108 3.944
Total 20699.000 120
Corrected total 3634.325 119
a R squared = 0.882 (adjusted R squared = 0.877).
Table 7 Multiple comparisons among rating of the four groups.
(I) Groupblk (J) Groupblk Mean diﬀerence (I–J) Std. Error Sig. 95% Conﬁdence Interval
Lower Bound Upper Bound
Group1 Group2 4.3000* .50057 .000 2.9948 5.6052
Group3 9.5667* .50057 .000 8.2615 10.8718
Group4 13.6333* .50057 .000 12.3282 14.9385
Group2 Group1 4.3000* .50057 .000 5.6052 2.9948
Group3 5.2667* .50057 .000 3.9615 6.5718
Group4 9.3333* .50057 .000 8.0282 10.6385
Group3 Group1 9.5667* .50057 .000 10.8718 8.2615
Group2 5.2667* .50057 .000 6.5718 3.9615
Group4 4.0667* .50057 .000 2.7615 5.3718
Group4 Group1 13.6333* .50057 .000 14.9385 12.3282
Group2 9.3333* .50057 .000 10.6385 8.0282
Group3 4.0667* .50057 .000 5.3718 2.7615
* The mean difference is signiﬁcant at the .05 level.
Table 8 Multiple comparisons among evaluators.
(I) Evaluator (J) Evaluator Mean diﬀerence (I–J) Std. error Sig.*
First evaluator Second evaluator 8.327E-17 .444 1.000
Third evaluator .225 .444 .613
Second evaluator First evaluator 8.327E17 .444 1.000
Third evaluator .225 .444 .613
Third evaluator First evaluator .225 .444 .613
Second evaluator .225 .444 .613
* p< 0.05.
794 A.-S.A. Haffor, M. Ismaeelbronchial asthma with different levels of severity. The system
correlated with peak expiratory ﬂow (PEF), wheezing
(WHZ), frequency of respiration (FR) and heart rate (HR).
An advantage of this classiﬁcation is its suitability for use by
general practitioners who play a vital role in the management
of asthma but its use for radiological and pulmonary function
testing is not extensive. Airway inﬂammation has been widely
demonstrated in all forms of asthma and an association
between the extent of an inﬂammation and the clinical severity
of asthma has been demonstrated in some studies [5,30,19]. It
has been accepted that the inﬂammation involves the whole
bronchial tree, both central and peripheral [36,37]. Therefore
the morphological alterations of the bronchial tree on CXRare reﬂected in peak expiratory ﬂow (PEF) as well as some
clinical signs such as wheezing (WHZ), frequency of respira-
tion (FR) and heart rate (HR). Asthma has become common
disease [12,29], and its management requires extensive role
by general practitioners who may rely on evaluating vital signs
and osculating breathing and wheezing.
According to our results, there is a strong, positive correla-
tion between the regularly measured physiological measures
such as HR, FR, WHZ and the modiﬁed S–K rating scale.
These variables are ideally performed at the medical ofﬁce
by the primary care physician. In view of this strong correla-
tion, the S–K score needs only one observer and does not
require a lateral CXR. The scale for overall assessment may
Figure 1 Consistency among evaluators for all S–K levels.
Grading chest X-ray in adult asthma 795allow for changes and complications, both acute and chronic,
which gives the score more ﬂexibility, hence providing infor-
mation essential for asthmatic patient management. The S–K
chest radiograph scoring system fulﬁlls the demands made of
an effective rating scale. Furthermore, the S–K score can be
conducted by a single physician who is working in a typical
asthma outpatient clinic. Current trend has been focusing on
the management of asthma treatment rather than diagnosis.
Many guidelines such as NAEPP and NAG [32] (NAEPP,
2014) recommended more simple monitoring strategies as its
assessment and monitoring based on PFT require depth of
knowledge regarding the complexity of pathophysiologic
mechanisms involved.
The ﬁndings of the presence of bilateral peri-bronchial
thickening with tram-track pattern associated with branched
bronchial thickness as well as pulmonary nodules associated
with segmental atelectasis were reported previously in moder-
ate asthma conditions [9,18,26,8,14]. They attributed the latter
changes to mucus hypersecretion and blocking associated with
obvious vascular abnormalities as well as abnormal heart size
and shadow [38,40,24]. In the severe asthma group, there was
extensive atelectasis secondary to obstruction and infection
mainly due to bronchiolitis and/or signs of right heart failure
has been conﬁrmed previously [17,4,15,16,43,23,33,28].
Although our study was not designed to explore reasons for
airway morphological changes and/or remodeling, its ﬁndings
provided an objective quantitative rating scoring numerical
measure regarding qualitative indications on CXR of chronic
asthma patients. Bousquet et al. studied 452 asthmatic patients
using high resolution computed tomography and found an
increase in ﬁxed abnormality that was dependent on the sever-
ity of asthma and that included bronchial wall thickening, sec-
ondary line shadows and emphysema-like images secondary to
a cicatrical peri-bronchial ﬁbrosis [6]. They emphasized that
chronic inﬂammation induced wall thickness [20,21] involved
membranous and cartilaginous airways of asthmatic patientsand the airway smooth muscle shortening required to occlude
the lumen was less in asthmatic than non-asthmatic airways.
Therefore, the increased wall thickness was due to increased
areas of epithelium, muscle, and submucosa that could be as
crucial as smooth muscle shortening in determining the airway
responsiveness. Some studies have found that emphysema may
be present in subset of asthmatic patients due to respiratory
airspace enlargement secondary to ﬁbrotic change and remod-
eling of wall of the airways, rather than direct destruction of
the distal airspace as in emphysema patients [16,33].
The early work of Shwachman–Kulczycki – SK presented
an easy and applied routine to rate the severity of cystic ﬁbro-
sis, hence provided a perception of the overall morphological
status of the patient’s lungs [39,10] as observed on CXR. How-
ever, the S–K rating lacked pulmonary function domain, clin-
ical signs domain and frequency of patients’ visitations
domain. In the present study, we modiﬁed S–K rating scale
to include four categories of asthmatic patients with different
PEF, different levels of wheezing, different levels of frequency
of respiration and different levels of heart rate. These domains
corroborate our idea that the inﬂammation-induced-altera-
tions are in the morphological aspects of the airway wall thick-
ness [17] [26,4] and their related consequences that had
included physiological signs during the primary physician’s
visits. Therefore, the modiﬁed S–K rating scale of the present
study compared the progression of functional decline and its
associated physiological signs. Furthermore, the peripheral air-
ways and the adjacent muscular pulmonary arteries were stud-
ied by morphometric methods in the autopsy lungs of six
asthmatic subjects who died suddenly during an asthma
attack, and they were compared with those of six control sub-
jects who died of other causes and had no history of respira-
tory diseases. Bronchioles of asthmatic subjects had an
increased amount of lumen occlusion, smooth muscle thick-
ness, and inﬂammatory inﬁltrate, and both mononuclear cells
and eosinophils contributed to this increased inﬂammation.
796 A.-S.A. Haffor, M. IsmaeelThe muscular pulmonary arteries adjacent to occluded and
inﬂamed bronchioles did not have the morphologic features
of chronic hypoxia, as shown by the normal medial and inti-
mal thickness, but they had an important inﬂammatory pro-
cess in their walls that was particularly marked at sites
adjacent to airways [13,36].
The relationships between pulmonary function and radiol-
ogy have been described in the literature [3,4,10,26]. It has
also been emphasized that the ideal radiological scoring
system should reﬂect clinical status and functional loss
[7,8,13,17,18,27]. However PFT procedures require effort and
cooperation from patients and that may impact the sensitivity
of PFT results. Furthermore PFT results are time dependent
with respect to the occurrences of asthma episode hence it
becomes a mixed indication for both acute and chronic inﬂam-
mation in response to different pulmonary diseases [3,34]. Stud-
ies of actual care have indicated that lung functions including;
forced expiratory volume in one second (FEV1), forced expira-
tory volume in six seconds, forced vital capacity (FVC), FEV1/
FVC ratio, ﬂow volume loop (FVL), exercise-induced asthma
and methacholine challenge test are required under some cir-
cumstances for proper differentiation and evaluation of asthma
and require many specialized pulmonary staff and that may not
be available in outpatient clinic and primary physician ofﬁces
which are essential point of entry in primary care for asthma
patients.
Conclusion
In conclusion, the Shwachman–Kulczycki CXR rating score
reﬂects the severity status of asthmatic patient, and its impor-
tance lies in the fact that it correlates with regularly measured
parameters such as PEF, FR, HR and WHZ in outpatient
clinic and/or general practitioner physician. Our study was
limited by the small sample size but contributes to expanding
knowledge of asthma management in terms of early diagnosis,
follow-up treatment and referral.
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